Get started
Work

Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors

Year: 2009
Type: article
DOI: 10.1007/s00228-009-0725-5
Authors: Todd Hulgan, John P. Donahue, Laura Smeaton, Minya Pu, Hongying Wang, Michael M. Lederman, Kimberly Smith, Hernan Valdez, Christopher Pilcher, David W. Haas
Institutions: Vanderbilt University, Harvard University, University of California San Diego, Case Western Reserve University, Rush University Medical Center, Pfizer (United States), University of California, San Francisco
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
Awards: G118038628, G1185407416, G1276011396, G1348836791, Vanderbilt HIV Clinical Trials Unit, G1939027404, G2027736814, G2239548760, G279802914, University of North Carolina AIDS Clinical Trials Unit (UNC ACTU), G3290139526, G3672534956, Vanderbilt Meharry Center for AIDS Research, G4585356076, G4614481423, G5129793090, G5401123494, G650174051, G7140541060, Vanderbilt Mentored Clinical Research Scholar Program, G845393165, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Rustbelt Center for AIDS Research (Case/UHC-Pitt CFAR), The University of North Carolina Center for AIDS Research, University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit, Vanderbilt HIV Clinical Trials Unit (CTU)
OpenAlex ID: W2015351195
FWCI: 0.165
Cites: 50
Cited by: 4
Related to: 10